Volume 100, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



The aim of our study was to describe the clinical features, the etiologies, and the factors associated with poor outcome of encephalitis in French Guiana. Our study was retrospective, including all cases of encephalitis hospitalized in the Cayenne General Hospital, from January 2007 to July 2017. Patients were included through the 2013 encephalitis consortium criteria and the outcome was evaluated using the Glasgow outcome scale at 3 months from the diagnosis of encephalitis. We included 108 patients, giving an approximate incidence rate of four cases/100,000 inhabitants/year. The origin of the encephalitis was diagnosed in 81 cases (75%), and 72 of them (66.7%) were from an infectious origin. The most common infectious causes were sp. (18.5%) independently of the immune status, (13.9%), and (5.5%). In the follow-up, 48 patients (46.6%) had poor outcome. Independent risk factors associated with poor outcome at 3 months were “coming from inside area of the region” ( = 0.036, odds ratio [OR] = 4.19; CI 95% = 1.09–16.06), need for mechanical ventilation ( = 0.002, OR = 5.92; CI 95% = 1.95–17.95), and age ≥ 65 years ( = 0.049, OR = 3.99; CI 95% = 1.01–15.89). The most identified cause of encephalitis in French Guiana was . The shape of the local epidemiology highlights the original infectious situation with some local specific pathogens.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Venkatesan A, International Encephalitis Consortium , 2013. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis 57: 11141128. [Google Scholar]
  2. Boucher A, Herrmann JL, Morand P, Buzelé R, Crabol Y, Stahl JP, Mailles A, , 2017. Epidemiology of infectious encephalitis causes in 2016. Med Mal Infect 47: 221235. [Google Scholar]
  3. Franco-Paredes C, Womack T, Bohlmeyer T, Sellers B, Hays A, Patel K, Lizarazo J, Lockhart SR, Siddiqui W, Marr KA, , 2015. Management of Cryptococcus gattii meningoencephalitis. Lancet Infect Dis 15: 348355. [Google Scholar]
  4. Glaser CA, 2006. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis 43: 15651577. [Google Scholar]
  5. Yang S, Rothman RE, , 2004. PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings. Lancet Infect Dis 4: 337348. [Google Scholar]
  6. Mailles A, Stahl JP, Steering Committee and Investigators Group; , 2009. Infectious encephalitis in France in 2007: a national prospective study. Clin Infect Dis 49: 18381847. [Google Scholar]
  7. George BP, Schneider EB, Venkatesan A, , 2014. Encephalitis hospitalization rates and inpatient mortality in the United States, 2000–2010. PLoS One 9: e104169. [Google Scholar]
  8. Granerod J, Crowcroft NS, , 2007. The epidemiology of acute encephalitis. Neuropsychol Rehabil 17: 406428. [Google Scholar]
  9. Granerod J, UK Health Protection Agency (HPA) Aetiology of Encephalitis Study Group , 2010. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 10: 835844. [Google Scholar]
  10. Venkatesan A, , 2015. Epidemiology and outcomes of acute encephalitis. Curr Opin Neurol 28: 277282. [Google Scholar]
  11. Lancaster E, , 2016. The diagnosis and treatment of autoimmune encephalitis. J Clin Neurol 12: 113. [Google Scholar]
  12. Nightingale S, Winsto A, Letendre S, Michael BD, McArthur JC, Khoo S, Solomon T, , 2014. Controversies in HIV-associated neurocognitive disorders. Lancet Neurol 13: 11391151. [Google Scholar]
  13. Mailles A, Steering Committee and Investigators Group , 2012. Long-term outcome of patients presenting with acute infectious encephalitis of various causes in France. Clin Infect Dis 54: 14551464. [Google Scholar]
  14. Thakur KT, Motta M, Asemota AO, Kirsch HL, Benavides DR, Schneider EB, McArthur JC, Geocadin RG, Venkatesan A, , 2013. Predictors of outcome in acute encephalitis. Neurology 81: 793800. [Google Scholar]
  15. Nacher M, Vantilcke V, Parriault MC, Van Melle A, Hanf M, Labadie G Romeo M, Adriouch L, Carles G, Couppié P, , 2010. What is driving the HIV epidemic in French Guiana? Int J STD AIDS 21: 359361. [Google Scholar]
  16. Dromer F, Mathoulin-Pélissier S, Launay O, Lortholary O, French Cryptococcosis Study Group; , 2007. Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study. PLoS Med 4: e21. [Google Scholar]
  17. Flamand C, 2017. Epidemiological assessment of the severity of dengue epidemics in French Guiana. PLoS One 12: e0172267. [Google Scholar]
  18. Fritzell C, Raude J, Adde A, Dusfour I, Quenel P, Flamand C, , 2016. Knowledge, attitude and practices of vector-borne disease prevention during the emergence of a new arbovirus: implications for the control of chikungunya virus in French Guiana. PLoS Negl Trop Dis 10: e0005081. [Google Scholar]
  19. Kamel MG, 2017. Post-dengue acute disseminated encephalomyelitis: a case report and meta-analysis. PLoS Negl Trop Dis 11: e0005715. [Google Scholar]
  20. Atallah A, Atallah V, Daigre JL, Boissin JL, Kangambega P, Larifla L, Inamo J, , 2014. High blood pressure and obesity: disparities among four French overseas territories. Ann Cardiol Angeiol (Paris) 63: 155162. [Google Scholar]
  21. Vora NM, Holman RC, Mehal JM, Steiner CA, Blanton J, Sejvar J, , 2014. Burden of encephalitis-associated hospitalizations in the United States, 1998–2010. Neurology 82: 443451. [Google Scholar]
  22. Grouille J, Maillot F, De Toffol B, Perrotin D, Bernard L, Garot D, , 2017. Meningoencephalitis: a 4-year retrospective study in the University Hospital of Tours (France). Rev Med Interne 38: 9096. [Google Scholar]
  23. Olsen SJ, Sadones H, Ong S, Mam M, Yim C, Sor S, Grosjean P, Reynes JM, Grosjean P, Reynes JM, , 2015. Infectious causes of encephalitis and meningoencephalitis in Thailand, 2003–2005. Emerg Infect Dis 21: 280289. [Google Scholar]
  24. Srey VH, Sadones H, Ong S, Mam M, Yim C, Sor S, Grosjean P, Reynes JM, Grosjean P, Reynes JM, , 2002. Etiology of encephalitis syndrome among hospitalized children and adults in Takeo, Cambodia, 1999–2000. Am J Trop Med Hyg 66: 200207. [Google Scholar]
  25. Debourgogne A, Iriart X, Blanchet D, Veron V, Boukhari R, Nacher M, Carme B, Aznar C, , 2011. Characteristics and specificities of Cryptococcus infections in French Guiana, 1998–2008. Med Mycol 49: 864871. [Google Scholar]
  26. Kwon-Chung KJ, Fraser JA, Doering TL, Wang Z, Janbon G, Idnurm A, Bahn YS, , 2014. Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis. Cold Spring Harb Perspect Med 4: a019760. [Google Scholar]
  27. Pommier de Santi V, Trochu J, Gardon J, Laventure S, Hommel D, Lelarge J, Labeau B, Digoutte JP, Hulin A, Sarthou JL, , 2018. Q fever epidemic in Cayenne, French Guiana, epidemiologically linked to three-toed sloth. Comp Immunol Microbiol Infect Dis 56: 3438. [Google Scholar]
  28. Aznar C, La Ruche G, Laventure S, Carme B, Liegeard P, Hontebeyrie M, , 2004. Seroprevalence of Trypanosoma cruzi infection in French Guiana. Mem Inst Oswaldo Cruz 99: 805808. [Google Scholar]
  29. Talarmin A, Trochu J, Gardon J, Laventure S, Hommel D, Lelarge J, Labeau B, Digoutte JP, Hulin A, Sarthou JL, , 2001. Tonate virus infection in French Guiana: clinical aspects and seroepidemiologic study. Am J Trop Med Hyg 64: 274279. [Google Scholar]
  30. Berger F, Desplanches N, Baillargeaux S, Joubert M, Miller M, Ribadeau-Dumas F, Spiegel A, Bourhy H, , 2013. Rabies risk: difficulties encountered during management of grouped cases of bat bites in 2 isolated villages in French Guiana. PLoS Negl Trop Dis 7: e2258. [Google Scholar]
  31. Graus F, 2016. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15: 391404. [Google Scholar]
  32. Titulaer MJ, 2013. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12: 157165. [Google Scholar]
  33. Tenembaum S, Chitnis T, Ness J, Hahn JS, , 2007. Acute disseminated encephalomyelitis. Neurology 68: S23S36. [Google Scholar]
  34. Joshi R, Mishra PK, Joshi D, Santhosh SR, Parida MM, Desikan P, Gangane N, Kalantri SP, Reingold A, Colford JM, Jr., 2013. Clinical presentation, etiology, and survival in adult acute encephalitis syndrome in rural central India. Clin Neurol Neurosurg 115: 17531761. [Google Scholar]
  35. Schmidt A, Bühler R, Mühlemann K, Hess CW, Täuber MG, , 2011. Long-term outcome of acute encephalitis of unknown aetiology in adults. Clin Microbiol Infect 17: 621626. [Google Scholar]
  36. Huy NT, Thao NT, Diep DT, Kikuchi M, Zamora J, Hirayama K, , 2010. Cerebrospinal fluid lactate concentration to distinguish bacterial from aseptic meningitis: a systemic review and meta-analysis. Crit Care 14: R240. [Google Scholar]
  37. Cunha BA, , 2013. Repeat lumbar puncture: CSF lactic acid levels are predictive of cure with acute bacterial meningitis. J Clin Med 2: 328330. [Google Scholar]
  38. Chow SL, Rooney ZJ, Cleary MA, Clayton PT, Leonard JV, , 2005. The significance of elevated CSF lactate. Arch Dis Child 90: 11881189. [Google Scholar]
  39. Bernard S, Mailles A, Stahl JP, Steering Committee and Investigators Group; , 2013. Epidemiology of infectious encephalitis, differences between a prospective study and hospital discharge data. Epidemiol Infect 141: 22562268. [Google Scholar]
  40. Granerod J, Cousens S, Davies NWS, Crowcroft NS, Thomas SL, , 2013. New estimates of incidence of encephalitis in England. Emerg Infect Dis 19: 14551462. [Google Scholar]

Data & Media loading...

  • Received : 11 Apr 2018
  • Accepted : 10 Jul 2018
  • Published online : 17 Dec 2018

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error